Synapse

← Wylie Vale

Papers by Wylie Vale

Page 2 · newest first

  1. Stressin1-A, a Potent Corticotropin Releasing Factor Receptor 1 (CRF1)-Selective Peptide AgonistJournal of Medicinal Chemistry · 2007
  2. Urocortin 3 regulates glucose-stimulated insulin secretion and energy homeostasisProceedings of the National Academy of Sciences · 2007
  3. The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stressDialogues in Clinical Neuroscience · 2006
  4. Cripto Binds Transforming Growth Factor β (TGF-β) and Inhibits TGF-β SignalingMolecular and Cellular Biology · 2006
  5. erbB2 is required for G protein-coupled receptor signaling in the heartProceedings of the National Academy of Sciences · 2006
  6. The Effect of Lateral Septum Corticotropin-Releasing Factor Receptor 2 Activation on Anxiety Is Modulated by StressJournal of Neuroscience · 2006
  7. Cocaine withdrawal enhances long‐term potentiation induced by corticotropin‐releasing factor at central amygdala glutamatergic synapses via CRF₁, NMDA receptors and PKAEuropean Journal of Neuroscience · 2006
  8. Pituitary actions of ligands of the TGF-β family: activins and inhibinsReproduction · 2006
  9. The Three‐Dimensional Structure of the N‐Terminal Domain of Corticotropin‐Releasing Factor ReceptorsAnnals of the New York Academy of Sciences · 2006
  10. Urocortin 3 Modulates the Neuroendocrine Stress Response and Is Regulated in Rat Amygdala and Hypothalamus by Stress and GlucocorticoidsEndocrinology · 2006
  11. Urocortin 2-Deficient Mice Exhibit Gender-Specific Alterations in Circadian Hypothalamus–Pituitary–Adrenal Axis and Depressive-Like BehaviorJournal of Neuroscience · 2006
  12. Structure of the ternary signaling complex of a TGF-β superfamily memberProceedings of the National Academy of Sciences · 2006
  13. Identification of Distinct Inhibin and Transforming Growth Factor β-binding Sites on BetaglycanJournal of Biological Chemistry · 2006
  14. Vital functions of corticotropin-releasing factor (CRF) pathways in maintenance and regulation of energy homeostasisProceedings of the National Academy of Sciences · 2006
  15. Cocaine- and Amphetamine-Regulated Transcript Is Localized in Pituitary Lactotropes and Is Regulated during LactationEndocrinology · 2005
  16. An Activin-A/C Chimera Exhibits Activin and Myostatin Antagonistic PropertiesJournal of Biological Chemistry · 2005
  17. A soluble mouse brain splice variant of type 2α corticotropin-releasing factor (CRF) receptor binds ligands and modulates their activityProceedings of the National Academy of Sciences · 2005
  18. Chronic Cocaine Administration Switches Corticotropin-Releasing Factor2Receptor-Mediated Depression to Facilitation of Glutamatergic Transmission in the Lateral SeptumJournal of Neuroscience · 2005
  19. Activins and Inhibins and Their SignalingAnnals of the New York Academy of Sciences · 2004
  20. Mouse Corticotropin-Releasing Factor Receptor Type 2α Gene: Isolation, Distribution, Pharmacological Characterization and Regulation by Stress and GlucocorticoidsMolecular Endocrinology · 2004
  21. Colocalization of urocortin and neuronal nitric oxide synthase in the hypothalamus and Edinger‐Westphal nucleus of the ratThe Journal of Comparative Neurology · 2004
  22. NMR structure and peptide hormone binding site of the first extracellular domain of a type B1 G protein-coupled receptorProceedings of the National Academy of Sciences · 2004
  23. Cardiovascular Effects of Long-Term Central and Peripheral Administration of Urocortin, Corticotropin-Releasing Factor, and Adrenocorticotropin in SheepEndocrinology · 2004
  24. Cocaine- and Amphetamine-Regulated Transcript Activates the Hypothalamic-Pituitary-Adrenal Axis through a Corticotropin-Releasing Factor Receptor-Dependent MechanismEndocrinology · 2004
  25. Corticotropin-Releasing Factor Receptors CRF1and CRF2Exert Both Additive and Opposing Influences on Defensive Startle BehaviorJournal of Neuroscience · 2004
  26. An Activin Mutant with Disrupted ALK4 Binding Blocks Signaling via Type II ReceptorsJournal of Biological Chemistry · 2004
  27. Corticotropin-Releasing Factor and Urocortin I Modulate Excitatory Glutamatergic Synaptic TransmissionJournal of Neuroscience · 2004
  28. Ligand Affinity for Amino-Terminal and Juxtamembrane Domains of the Corticotropin Releasing Factor Type I Receptor: Regulation by G-Protein and Nonpeptide AntagonistsBiochemistry · 2004
  29. The cardiovascular physiologic actions of urocortin II: Acute effects in murine heart failureProceedings of the National Academy of Sciences · 2004
  30. Selective Activation of Corticotropin-Releasing Factor-2 Receptors on Neurochemically Identified Neurons in the Rat Dorsal Raphe Nucleus Reveals Dual ActionsJournal of Neuroscience · 2004
  31. CRF and CRF Receptors: Role in Stress Responsivity and Other BehaviorsThe Annual Review of Pharmacology and Toxicology · 2004
  32. Urocortin II Gene Is Highly Expressed in Mouse Skin and Skeletal Muscle Tissues: Localization, Basal Expression in Corticotropin-Releasing Factor Receptor (CRFR) 1- and CRFR2-Null Mice, and Regulation by GlucocorticoidsEndocrinology · 2004
  33. Specificity and Regulation of Extracellularly Regulated Kinase1/2 Phosphorylation through Corticotropin-Releasing Factor (CRF) Receptors 1 and 2β by the CRF/Urocortin Family of PeptidesEndocrinology · 2003
  34. Urocortin-II and Urocortin-III Are Cardioprotective against Ischemia Reperfusion Injury: An Essential Endogenous Cardioprotective Role for Corticotropin Releasing Factor Receptor Type 2 in the Murine HeartEndocrinology · 2003
  35. The effect of urocortin on ingestive behaviours and brain Fos immunoreactivity in miceEuropean Journal of Neuroscience · 2003
  36. Expression of CRF1 and CRF2 Receptors in Human CancersThe Journal of Clinical Endocrinology & Metabolism · 2003
  37. Increased Depression-Like Behaviors in Corticotropin-Releasing Factor Receptor-2-Deficient Mice: Sexually Dichotomous ResponsesJournal of Neuroscience · 2003
  38. Identification of a Functional Binding Site for Activin on the Type I Receptor ALK4Journal of Biological Chemistry · 2003
  39. Glucocorticoids Regulate the Expression of the Mouse Urocortin II Gene: A Putative Connection between the Corticotropin-Releasing Factor Receptor PathwaysMolecular Endocrinology · 2003
  40. Corticotropin-Releasing Factor Receptor-2-Deficient Mice Display Abnormal Homeostatic Responses to Challenges of Increased Dietary Fat and ColdEndocrinology · 2003
  41. A Soluble Form of the First Extracellular Domain of Mouse Type 2β Corticotropin-releasing Factor Receptor Reveals Differential Ligand SpecificityJournal of Biological Chemistry · 2003
  42. Six Novel Gonadotropin-Releasing Hormones Are Encoded as Triplets on Each of Two Genes in the Protochordate,Ciona intestinalisEndocrinology · 2003
  43. Urocortin III Is Expressed in Pancreatic β-Cells and Stimulates Insulin and Glucagon SecretionEndocrinology · 2003
  44. Cripto forms a complex with activin and type II activin receptors and can block activin signalingProceedings of the National Academy of Sciences · 2003
  45. Corticotropin-Releasing Factor Receptor Type 2 Messenger Ribonucleic Acid in Rat Pituitary: Localization and Regulation by Immune Challenge, Restraint Stress, and GlucocorticoidsEndocrinology · 2003
  46. Inhibin Is an Antagonist of Bone Morphogenetic Protein SignalingJournal of Biological Chemistry · 2003
  47. Rat Anterior Pituitary Folliculostellate Cells Are Targets of Interleukin-1β and a Major Source of Intrapituitary FollistatinEndocrinology · 2003
  48. Structural Basis of BMP Signaling Inhibition by Noggin, a Novel Twelve-Membered Cystine Knot ProteinJournal of Bone and Joint Surgery · 2003
  49. Regulation of Follicle-Stimulating Hormone Secretion by the Interactions of Activin-A, Dexamethasone and Testosterone in Anterior Pituitary Cell Cultures of Male RatsNeuroendocrinology · 2003
  50. Residues in the C-terminal region of activin A determine specificity for follistatin and type II receptor bindingJournal of Endocrinology · 2003